Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul N Prasad

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Translational Lung Cancer Research|November 19, 2020
A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancerRahul N Prasad, Terence M Williams
Advances in Radiation Oncology|March 14, 2022
COVID-19 Booster Vaccine Equity for Patients With CancerRahul N Prasad, Manali Patel, Joshua D Palmer
Frontiers in Oncology|February 28, 2022
Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase StudiesRahul N Prasad, Eric D Miller, Daniel Addison, et al.
Advances in Radiation Oncology|May 27, 2022
Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation TherapyRahul N Prasad, Trevor J Royce, Fumiko Chino, et al.
Advances in Radiation Oncology|January 24, 2022
Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation TherapyRahul N Prasad, Vedat O Yildiz, Tejash Patel, et al.
Journal of Radiosurgery and SBRT|December 13, 2018
Linac-based fractionated stereotactic radiosurgery for high-risk meningiomaRahul N Prasad, John C Breneman, Timothy Struve, et al.
Advances in Radiation Oncology|October 18, 2021
Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes StudyRahul N Prasad, Tejash T Patel, Scott W Keith, et al.
American Journal of Clinical Oncology|June 22, 2024
Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation OncologistsAlex R Ritter, Rahul N Prasad, Sachin R Jhawar, et al.
Radiation Oncology Journal|July 7, 2022
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester diseaseRahul N Prasad, Peter J Kobalka, Haley K Perlow, et al.
Brachytherapy|November 8, 2022
Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United StatesRahul N Prasad, Yevgeniya Gokun, Alex R Ritter, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Translational Lung Cancer Research|November 19, 2020
A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancerRahul N Prasad, Terence M Williams
Advances in Radiation Oncology|March 14, 2022
COVID-19 Booster Vaccine Equity for Patients With CancerRahul N Prasad, Manali Patel, Joshua D Palmer
Frontiers in Oncology|February 28, 2022
Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase StudiesRahul N Prasad, Eric D Miller, Daniel Addison, et al.
Advances in Radiation Oncology|May 27, 2022
Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation TherapyRahul N Prasad, Trevor J Royce, Fumiko Chino, et al.
Advances in Radiation Oncology|January 24, 2022
Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation TherapyRahul N Prasad, Vedat O Yildiz, Tejash Patel, et al.
Journal of Radiosurgery and SBRT|December 13, 2018
Linac-based fractionated stereotactic radiosurgery for high-risk meningiomaRahul N Prasad, John C Breneman, Timothy Struve, et al.
Advances in Radiation Oncology|October 18, 2021
Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes StudyRahul N Prasad, Tejash T Patel, Scott W Keith, et al.
American Journal of Clinical Oncology|June 22, 2024
Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation OncologistsAlex R Ritter, Rahul N Prasad, Sachin R Jhawar, et al.
Radiation Oncology Journal|July 7, 2022
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester diseaseRahul N Prasad, Peter J Kobalka, Haley K Perlow, et al.
Brachytherapy|November 8, 2022
Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United StatesRahul N Prasad, Yevgeniya Gokun, Alex R Ritter, et al.
Pageof 3